nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.0434	0.0434	CcSEcCtD
Tobramycin—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.0347	0.0347	CcSEcCtD
Tobramycin—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.03	0.03	CcSEcCtD
Tobramycin—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.0292	0.0292	CcSEcCtD
Tobramycin—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.0287	0.0287	CcSEcCtD
Tobramycin—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.0279	0.0279	CcSEcCtD
Tobramycin—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.0274	0.0274	CcSEcCtD
Tobramycin—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.0274	0.0274	CcSEcCtD
Tobramycin—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.0244	0.0244	CcSEcCtD
Tobramycin—Delirium—Riluzole—amyotrophic lateral sclerosis	0.024	0.024	CcSEcCtD
Tobramycin—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.0229	0.0229	CcSEcCtD
Tobramycin—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.0226	0.0226	CcSEcCtD
Tobramycin—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.022	0.022	CcSEcCtD
Tobramycin—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.0218	0.0218	CcSEcCtD
Tobramycin—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.0207	0.0207	CcSEcCtD
Tobramycin—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.0176	0.0176	CcSEcCtD
Tobramycin—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.0172	0.0172	CcSEcCtD
Tobramycin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0168	CcSEcCtD
Tobramycin—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0159	0.0159	CcSEcCtD
Tobramycin—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.014	0.014	CcSEcCtD
Tobramycin—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0137	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0135	CcSEcCtD
Tobramycin—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0132	CcSEcCtD
Tobramycin—Asthma—Riluzole—amyotrophic lateral sclerosis	0.013	0.013	CcSEcCtD
Tobramycin—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0125	CcSEcCtD
Tobramycin—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0117	CcSEcCtD
Tobramycin—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0116	CcSEcCtD
Tobramycin—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0116	CcSEcCtD
Tobramycin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Tobramycin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Tobramycin—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0109	CcSEcCtD
Tobramycin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0108	CcSEcCtD
Tobramycin—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0108	CcSEcCtD
Tobramycin—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0104	CcSEcCtD
Tobramycin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0103	CcSEcCtD
Tobramycin—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0102	CcSEcCtD
Tobramycin—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0102	CcSEcCtD
Tobramycin—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0102	CcSEcCtD
Tobramycin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.0097	0.0097	CcSEcCtD
Tobramycin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00942	0.00942	CcSEcCtD
Tobramycin—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00937	0.00937	CcSEcCtD
Tobramycin—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00935	0.00935	CcSEcCtD
Tobramycin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00885	0.00885	CcSEcCtD
Tobramycin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00874	0.00874	CcSEcCtD
Tobramycin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00838	0.00838	CcSEcCtD
Tobramycin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00835	0.00835	CcSEcCtD
Tobramycin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00825	0.00825	CcSEcCtD
Tobramycin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00815	0.00815	CcSEcCtD
Tobramycin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00812	0.00812	CcSEcCtD
Tobramycin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00809	0.00809	CcSEcCtD
Tobramycin—Cough—Riluzole—amyotrophic lateral sclerosis	0.00788	0.00788	CcSEcCtD
Tobramycin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00769	0.00769	CcSEcCtD
Tobramycin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00769	0.00769	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00764	0.00764	CcSEcCtD
Tobramycin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.0076	0.0076	CcSEcCtD
Tobramycin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00743	0.00743	CcSEcCtD
Tobramycin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00737	0.00737	CcSEcCtD
Tobramycin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00723	0.00723	CcSEcCtD
Tobramycin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00722	0.00722	CcSEcCtD
Tobramycin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00716	0.00716	CcSEcCtD
Tobramycin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00703	0.00703	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00672	0.00672	CcSEcCtD
Tobramycin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00662	0.00662	CcSEcCtD
Tobramycin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00657	0.00657	CcSEcCtD
Tobramycin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00641	0.00641	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00637	0.00637	CcSEcCtD
Tobramycin—Pain—Riluzole—amyotrophic lateral sclerosis	0.0063	0.0063	CcSEcCtD
Tobramycin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00608	0.00608	CcSEcCtD
Tobramycin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00603	0.00603	CcSEcCtD
Tobramycin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00586	0.00586	CcSEcCtD
Tobramycin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00583	0.00583	CcSEcCtD
Tobramycin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00583	0.00583	CcSEcCtD
Tobramycin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00543	0.00543	CcSEcCtD
Tobramycin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00529	0.00529	CcSEcCtD
Tobramycin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00522	0.00522	CcSEcCtD
Tobramycin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00504	0.00504	CcSEcCtD
Tobramycin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00488	0.00488	CcSEcCtD
Tobramycin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00469	0.00469	CcSEcCtD
Tobramycin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00465	CcSEcCtD
Tobramycin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00464	0.00464	CcSEcCtD
Tobramycin—Headache—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00462	CcSEcCtD
Tobramycin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00438	0.00438	CcSEcCtD
